SLTM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.136400E-01
Normal-vs-Stage2
6.115600E-01
Normal-vs-Stage3
1.384780E-01
Normal-vs-Stage4
7.130800E-01
Stage1-vs-Stage2
1.625230E-01
Stage1-vs-Stage3
9.698000E-03
Stage1-vs-Stage4
5.974000E-01
Stage2-vs-Stage3
3.251800E-02
Stage2-vs-Stage4
6.789000E-01
Stage3-vs-Stage4
1.061580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.225200E-01
Normal-vs-AfricanAmerican
7.307000E-01
Normal-vs-Asian
1.869430E-01
Caucasian-vs-AfricanAmerican
5.059200E-01
Caucasian-vs-Asian
1.614950E-01
AfricanAmerican-vs-Asian
2.109600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.538600E-01
Normal-vs-Female
2.945600E-01
Male-vs-Female
7.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.427200E-01
Normal-vs-Age(41-60Yrs)
7.435800E-01
Normal-vs-Age(61-80Yrs)
2.118000E-01
Normal-vs-Age(81-100Yrs)
4.893000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.466200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.597200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.236400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.300400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.420100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.476000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.995180E-01
Normal-vs-Daily Drinker
4.938600E-01
Normal-vs-Weekly Drinker
2.910000E-01
Normal-vs-Occasional Drinker
7.376200E-01
Normal-vs-Social Drinker
3.954000E-01
Non Drinker-vs-Daily Drinker
6.683200E-01
Non Drinker-vs-Weekly Drinker
7.928200E-01
Non Drinker-vs-Occasional Drinker
1.674400E-01
Non Drinker-vs-Social Drinker
5.126800E-01
Daily Drinker-vs-Weekly Drinker
9.454600E-01
Daily Drinker-vs-Occasional Drinker
8.568100E-02
Daily Drinker-vs-Social Drinker
3.201000E-01
Weekly Drinker-vs-Occasional Drinker
2.044400E-01
Weekly Drinker-vs-Social Drinker
4.792000E-01
Occasional Drinker-vs-Social Drinker
5.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.041820E-01
Normal-vs-Grade 2
1.552450E-02
Normal-vs-Grade 3
3.350100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.710800E-01
Grade 1-vs-Grade 3
8.598200E-01
Grade 1-vs-Grade 4
1.041820E-01
Grade 2-vs-Grade 3
8.242400E-01
Grade 2-vs-Grade 4
1.552450E-02
Grade 3-vs-Grade 4
3.350100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.086200E-01
Normal-vs-NonDiabetic
5.980200E-01
Diabetic-vs-NonDiabetic
2.483200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.002000E-01
Normal-vs-NoPancreatitis
5.726800E-01
Pancreatitis-vs-NoPancreatitis
6.797000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.456400E-01
Normal-vs-N1
6.156400E-01
N0-vs-N1
8.481400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.724400E-01
Normal-vs-TP53-NonMutant
6.942200E-01
TP53-Mutant-vs-TP53-NonMutant
7.177400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
